Karim Temsamani - Chief Executive Officer Andy Christiansen - Chief Financial Officer Nick Lynton - Chief Legal and Privacy Officer Hello! And thank you for standing by. Welcome to the Cardlytics Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time all participants are in a listen only mode. After the speaker's presentation, there will be a question and answer session [Operator Instructions]. The rollout of our new ad server and user experience; our transition of the cloud, and ...

(1) Please see appendix for definitions. | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------------------------------------------------------|-------------|------------------------------------------|------------------------------|-------|----------------------------------------|-----------------------------------|------------------------------|-------| | | 2022 | Three Months Ended December 31, \n2021 | Change \nAMT | \n% | 2022 | Year Ended December 31, \n2021 | Change \nAMT | % | | Revenue | | ...

In May 2018, we entered into a Master Agreement and Schedule #1 to the Master Agreement (collectively, the "Master Agreement") with Chase, pursuant to which we provide Chase with access to the Cardlytics platform. Under the Master Agreement, we provide Chase with access to the Cardlytics platform through November 2025. Chase may terminate the Master Agreement at any time upon 90 days' written notice. The Master Agreement will automatically renew for 12-month periods thereafter, unless terminated earlier in ...

Cardlytics, Inc. (NASDAQ:CDLX) Q3 2022 Earnings Conference Call November 1, 2022 5:00 PM ET Company Representatives Nick Lynton - Chief Legal Officer Karim Temsamani - Chief Executive Officer Andy Christiansen - Chief Financial Officer Conference Call Participants Kyle Peterson - Needham Wesley Sanford - JPMorgan Aaron Kessler - Raymond James Operator Thank you for standing by, and welcome to the Third Quarter 2022 Cardlytics, Inc., Earnings Conference Call. I will now hand the conference over to Nick Lynto ...

| --- | --- | |-------------------------------------------|-------| | | | | | | | | | | CARDLYTICS Q3 2022 Earnings Presentation | | | November 1, 2022 | | Disclaimer This presentation includes forward-looking statements. All statements contained in this presentation other than statements of historical facts, including statements regarding expectations about future financial performance or results of Cardlytics, Inc. ("Cardlytics," "we," "us," or "our) including the potential benefits of our acquisitions of ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to _________________ Commission File Number: 001-38386 CARDLYTICS, INC. (Exact Name of Registrant as Specified in its Charter) Dela ...

Cardlytics, Inc. (NASDAQ:CDLX) Q2 2022 Earnings Conference Call August 2, 2022 5:00 PM ET Company Representatives Lynne Laube - Chief Executive Officer Andy Christiansen - Chief Financial Officer Nick Lynton - Chief Legal Officer Conference Call Participants Kyle Peterson - Needham Doug Anmuth - JPMorgan Jason Kreyer - Craig-Hallum Operator Hello! Thank you for standing by, and welcome to the Second Quarter 2022 Cardlytics, Inc., Earnings Conference Call. At this time all participants are in a listen-only m ...

| --- | --- | |-------------------------------------------|-------| | | | | | | | | | | | | | CARDLYTICS Q2 2022 Earnings Presentation | | | August 2, 2022 | | Disclaimer This presentation includes forward-looking statements. All statements contained in this presentation other than statements of historical facts, including statements regarding expectations about future financial performance or results of Cardlytics, Inc. ("Cardlytics," "we," "us," or "our) including the potential benefits of our acquisition ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to _________________ Commission File Number: 001-38386 CARDLYTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware ...

Cardlytics, Inc. (NASDAQ:CDLX) Q1 2022 Earnings Conference Call May 2, 2022 5:00 PM ET Company Participants Kirk Somers - Chief Legal & Privacy Officer Lynne Laube - Chief Executive Officer & Co-Founder Andy Christiansen - Chief Financial Officer Conference Call Participants Aaron Kessler - Raymond James Kyle Peterson - Needham Jason Kreyer - Craig-Hallum Jeff Cantwell - Wells Fargo Nat Schindler - Bank of America Operator Thank you for standing by, and welcome to the First Quarter 2022 Cardlytics, Inc. Ear ...